What is ATEX's health score?

Anterix Inc. (ATEX) has a TradeApes health score of 40 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ATEX's estimated fair value?

Based on our 5-year discounted cash flow model, Anterix Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is ATEX undervalued or overvalued?

Our model currently rates ATEX as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ATEX... Refresh in a moment for the full analysis.

Anterix Inc. (ATEX)

Communication Services Inconclusive inconclusive weak

$66.64

Updated: 2026-06-06

TradeApes Score

Financial Strength

50 Mixed

Operating Trend

50 Mixed

Relative Value

15 Stressed

Capital Allocation

30 Weak

Risk

70 Healthy

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Historically expensive — EV/EBITDA in top 20% of its 5-year range

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.